Growth Metrics

Bluejay Diagnostics (BJDX) Change in Inventory (2020 - 2022)

Bluejay Diagnostics recorded quarterly Change in Inventory of -$221924.0 in Q2 2022, down 124.85% quarter-over-quarter from $893174.0 in Q1 2022.

Bluejay Diagnostics' Change in Inventory history runs 2 years deep, the most recent figure standing at -$221924.0 for Q2 2022.

  • In Q2 2022, Change in Inventory changed N/A year-over-year to -$221924.0; the TTM figure through Jun 2022 stood at $671250.0 (changed N/A YoY), while the FY2021 annual figure was -$84762.0, down 118.76% from the prior year.
  • Change in Inventory came in at -$221924.0 for Q2 2022 at Bluejay Diagnostics, down from $893174.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $893174.0 in Q1 2022 to a low of -$221924.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 420.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 127.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 131.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -264.59 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 65.20 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 171.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -38.50 Mn
10 Bluejay Diagnostics 572,394.44 -3.11 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 -221,924.00
Jun 30, 2022 -221,924.00
Mar 31, 2022 893,174.00
Mar 31, 2022 893,174.00
Dec 31, 2020 -123,508.00
Dec 31, 2020 -123,508.00